Abstract: A synergistic antimicrobial composition containing lenacil and terbutryn is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: The invention relates to a shielded double-coil multilayer assembly intended to be used in an inductive detector. This multilayer assembly comprises a plurality of stacked parallel separated layers, namely: a layer (C1) comprising a first shielding element for a first coil, a layer (C2) comprising all or part of a first coil, a layer (C3) comprising all or part of a second coil, a layer (C4) comprising a first shielding element for the second coil.

Abstract: A synergistic antimicrobial composition containing lenacil and 3-iodine-2-propenyl-butylcarbamate is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: A synergistic antimicrobial composition containing lenacil and zinc pyrithione is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: A synergistic antimicrobial composition containing zoxamide and zinc pyrithione is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: The present invention relates to testosterone topical formulations, especially high testosterone concentration formulations, such as between about 6% to about 15% w/w or higher, for the controlled release of testosterone into the systemic circulation of males and females for providing constant effective testosterone blood levels, without inducing undesired testosterone spike in blood levels or testosterone transference, following topical administration.

Abstract: A synergistic antimicrobial composition containing zoxamide and one of 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one or 2-n-octyl-4-isothiazolin-3-one is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: A synergistic antimicrobial composition containing zoxamide and terbutryn is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.

Abstract: The present invention relates to pernasal testosterone bio-adhesive gel formulations for intranasal administration and testosterone replacement treatment methods for using the pernasal testosterone bio-adhesive gel formulations for providing sustained intranasal delivery of testosterone to testosterone deficient males to treat, for example, male subjects diagnosed with hypogonadism. The present invention is also concerned with a novel titration method to determine the appropriate daily treatment regimen, i.e., a BID or TID treatment regimen, to administer the intranasal gels of the present invention to treat hypogonadism or TRT.

Abstract: The present invention provides methods and formulations for reducing or inhibiting increase in the concentration of microbes in a water-based fluid. The methods and formulations of the present invention use an oxazolidine compound and a hydroxymethyl-substituted phosphorus compound selected from the group consisting of tetrakis(hydroxymethyl)phosphonium salts, C1-C3 alkyl- and alkenyltris(hydroxymethyl)phosphonium salts and tris(hydroxymethyl)phosphine. The methods and formulations of the present invention can be useful in treating water contaminated with aerobic or anaerobic bacteria in oilfield and other industrial applications.

Abstract: The subject of the invention is a process for the preparation of fluoroolefin compounds.

Abstract: A medical unit for injecting a patient with an elution solution containing rubidium 82, includes, elements for receiving a strontium/rubidium generator capable of producing an elution solution that contains the rubidium 82 and that is capable of being contaminated by strontium 82 and/or strontium 85. This medical unit includes: —own elements thereof for acquiring a value related to at least one safety parameter that is associated with a maximum threshold value corresponding to a potentially excessive contamination of the elution solution with strontium 82 and/or strontium 85, and —control elements including safety elements that are controlled in an active configuration when the acquired value reaches the maximum threshold value of the safety parameter, the safety elements being capable, in the active configuration, of operating the infusion elements to the stop position in order to prevent an injection of the elution solution into the patient.

Abstract: A pressure control valve for a high-pressure accumulator of an injection device of an internal combustion engine, includes a magnetic actuator. The magnetic actuator has a magnetic core with contacting pins and a magnetic armature with an armature plate. The contacting pins pass through feedthroughs formed in the armature plate. The armature plate is hydraulically connected by a pressure equalization channel to a valve chamber connected to low pressure. The pressure equalization channel has an opening on the magnetic core end face which opens into the armature space. At least one of the feedthroughs forms a passage for the fuel through the armature plate for the pressure equalization. A residual air gap disk is arranged between the magnetic core and the armature plate. The residual air gap disk forms an additional feedthrough with a radial extension that extends in the direction of the opening.

Abstract: An embodiment of a plasma ignition system for an internal combustion engine having up to N cylinders includes a power splitter, N phase shifters, N amplifiers, a power combiner network, and up to N radiation devices. The power splitter divides an input RF signal into N divided RF signals. Each phase shifter applies one of multiple pre-determined phase shifts to one of the N divided RF signals to produce N phase shifted RF signals. The N amplifiers amplify the N phase shifted RF signals to produce N amplified, phase shifted RF signals. The power combiner network combines the N amplified, phase shifted RF signals to produce N output RF signals. Each of the radiation devices receives one of the N output RF signals, and produces a plasma discharge when a power level of the output RF signal is sufficiently high.

Abstract: An annular turbine engine stator portion including a structural support provided in succession with a bonding underlayer and with an abradable coating formed by a resin filled with microbeads, the bonding underlayer for fastening the abradable coating to the structural support being formed by fiber reinforcement made of long fibers having a peripheral portion of the reinforcement that is secured to the structural support and having a central portion thereof that is impregnated with the resin filled with microbeads while the abradable coating is being fastened to the structural support.

Abstract: The invention relates to antibodies binding to the proteins forming adrenomedullin receptors, and to the uses thereof as a drug.

Abstract: The subject of the invention is a process for the preparation of fluoroolefin compounds.

Abstract: The invention relates to a method for preparing olefin fluorine compounds. Specifically, the invention relates to a method for producing a (hydro)fluoroolefin compound, including: (i) in an agitated reactor provided with at least one reactant inlet and at least one outlet, contacting, with potassium hydroxide in an aqueous reaction medium, at least one compound containing three to six carbon atoms, at least two fluorine atoms, and at least one hydrogen atom, with the proviso that at least one hydrogen atom and one fluorine atom are located on adjacent carbon atoms, so as produce the (hydro)fluoroolefin compound, separated in a gaseous state from the reaction medium and from potassium fluoride; (ii) in an aqueous medium, contacting the potassium fluoride formed in step (i) with calcium hydroxide in a second reactor so as to produce potassium.

Abstract: The present invention relates to a method for injecting a liquid in a porous material or a material including discontinuity interfaces, wherein said method includes the steps of: attaching an injection part to said material, the injection part defining a compression chamber with at least one surface of said material; injecting said liquid into said compression chamber under a low pressure; and applying a high-power acoustic wave to said liquid using a drawing element, wherein said drawing element extends into said compression chamber.

Abstract: The present invention relates to a polymerisation process, and in particular provides a process for the polymerisation of monomer in a polymerisation system having at least one component attached thereto which component is flushed with a flush medium which enters the polymerisation system, wherein initially said component is flushed with a first flush medium, and subsequently said component is flushed with a second flush medium.